DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 140 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q4 2023. The put-call ratio across all filers is 1.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $765 | -31.3% | 55,594 | -17.6% | 0.00% | – |
| Q1 2024 | $1,114 | -58.9% | 67,466 | -63.7% | 0.00% | -100.0% |
| Q4 2023 | $2,713 | +67.6% | 185,839 | +40.9% | 0.00% | 0.0% |
| Q3 2023 | $1,619 | -6.1% | 131,882 | -8.7% | 0.00% | 0.0% |
| Q2 2023 | $1,724 | +75.2% | 144,403 | +96.3% | 0.00% | – |
| Q1 2023 | $984 | -58.3% | 73,569 | -32.8% | 0.00% | -100.0% |
| Q4 2022 | $2,358 | -99.9% | 109,552 | +21.1% | 0.00% | -50.0% |
| Q3 2022 | $1,812,000 | +8528.6% | 90,429 | +7615.8% | 0.00% | – |
| Q2 2022 | $21,000 | -61.8% | 1,172 | -78.6% | 0.00% | – |
| Q1 2022 | $55,000 | – | 5,487 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,965,588 | $113,066,000 | 1.82% |
| Boxer Capital, LLC | 1,189,943 | $27,095,000 | 0.96% |
| BVF INC/IL | 918,975 | $20,925,000 | 0.78% |
| Samsara BioCapital, LLC | 202,500 | $4,611,000 | 0.57% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 818,980 | $18,648,000 | 0.33% |
| Perceptive Advisors | 1,512,094 | $34,430,000 | 0.22% |
| Rock Springs Capital Management LP | 373,739 | $8,510,000 | 0.17% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 434,423 | $9,892,000 | 0.13% |
| HealthCor Management, L.P. | 103,717 | $2,362,000 | 0.09% |
| VIKING GLOBAL INVESTORS LP | 1,341,396 | $30,544,000 | 0.09% |